bibliographic entry 5530319 [be/5530319]
https://w3id.org/oc/corpus/be/5530319

is a

• bibliographic reference

content

• Hochhaus A, Saglio G, Hughes TP, Larson RA, Kim DW, Issaragrisil S et al. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial. Leukemia 2016; 30: 1044–1054. PMID: 26837842

references

• https://w3id.org/oc/corpus/br/2024939